Health Catalyst Q3 revenue flat at $76.3M; net loss widens 51% to $22.2M

Health Catalyst, Inc.

2025-Q3 EPS reported -$1.25 vs consensus $0.06 ▼ miss (-2169.5%)

Total revenue $76.3M, flat YoY; gross margin 39%, up from 36%.
Net loss $22.2M, widened 51% from $14.7M in Q3 2024.
Adjusted EBITDA $12.0M; results beat quarterly guidance on both revenue and EBITDA.
FY 2025 guidance reaffirmed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.